🔎 Trials Near Me

Dachaigh › Leukemia myeloid geur › California › Sacramento

Sgrùdaidhean clionaigeach Leukemia myeloid geur ann an Sacramento, CA

Tha 12 sgrùdaidhean airson Leukemia myeloid geur a’ lorg phàirtichean aig làraichean ann agus timcheall air Sacramento (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

A’ fastadhÌre 2
  • Kaiser Permanente Downtown Commons, Sacramento
  • University of California Davis Comprehensive Cancer Center, Sacramento
  • Kaiser Permanente-South Sacramento, Sacramento
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT05564390

Olutasidenib With Azacitidine Followed by Olutasidenib Maintenance for the Treatment of IDH1-mutated Acute Myeloid Leukemia in Patients With Prior Treatment With Venetoclax Plus a Hypomethylating Agent

A’ fastadhÌre 2
  • University of California Davis Comprehensive Cancer Center, Sacramento
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07304011

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • Mercy Cancer Center - Sacramento, Sacramento
  • Woodland Memorial Hospital, Woodland · 16 mìle air falbh
Aoisean 40 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05334069

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

A’ fastadhÌre 1
  • UC Davis, Sacramento
Aoisean 12 gu 78 · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT03802695

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

A’ fastadhÌre 2
  • University of California Davis Comprehensive Cancer Center, Sacramento
Aoisean 18 gu 59 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

A’ fastadhÌre 2
  • Kaiser Permanente Downtown Commons, Sacramento
  • University of California Davis Comprehensive Cancer Center, Sacramento
  • Kaiser Permanente-South Sacramento, Sacramento
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

A’ fastadhÌre 3
  • University of California Davis Comprehensive Cancer Center, Sacramento
6 Months – 21 Years · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT04293562

CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)

A’ fastadhÌre 1
  • University of California, Davis Comprehensive Cancer Center, Sacramento
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT06834282

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

A’ fastadhSgrùdadh amharc
  • Sutter Medical Center, Sacramento
Gach aois · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT01351545

Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML

A’ fastadhÌre 2
  • University of California Davis Health (UC Davis Health), Sacramento
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Faoi 2026 · NCT05184842

Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia

A’ fastadhÌre 1/2
  • University of California, Davis, Sacramento
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 26 Lùna 2025 · NCT03850574

Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure

A’ fastadhÌre 2
  • University of California Davis Comprehensive Cancer Center, Sacramento
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Cèit 2024 · NCT04905810

Sgrùdaidhean Leukemia myeloid geur ann am bailtean eile

Sgrùdaidhean eile ann an Sacramento

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.